Fasting blood samples were obtained between the first and fifth day of the menstrual period/withdrawal bleeding. Prolactin, T, FT, and thyroid-stimulating hormone (TSH) were assessed by chemiluminescence immunometric assay (Beckman Unicel DxI 800; Snibe MAGLUMI 4000; Abbott Immulite 2000 analyzer). 17-α-Hydroxyprogesterone was measured using the enzyme-linked immunosorbent assay (ELISA). Plasma glucose was measured using the glucose oxidase method (Hitachi 7600 autoanalyzer). Plasma insulin was measured using a chemiluminescence immunometric assay (Roche e601 analyzer). Total cholesterol (CHOL), TG, HDL-c, and low-density lipoprotein cholesterol (LDL-c) were measured using the enzymatic colorimetric method (Hitachi 7600 autoanalyzer). Indices were calculated based on the following formulas.
Body mass index (BMI) = weight (kg)/height2 (m)
LAP = (WC (cm)–58) × TG (mmol/L) [9 (link)].
CVAI = –187.32 + 1.71 × age + 4.23 × BMI + 1.12 × WC (cm) + 39.76 × log10[TG (mmol/L) ] – 11.66 × HDL (mmol/L) [14 (link)].
VAI = [WC (cm)/[36.58 + (1.89 × BMI)]] × [TG (mmol/L)/0.81] × [1.52/HDL-C (mmol/L)] [15 (link)].
WTI = WC (cm) × TG (mmol/L) [15 (link)].
TyG = Ln (fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2) [17 (link)].